| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | cefuroxime sodium (Ximaract®) |
| Formulation | 50 mg powder for solution for injection |
| Reference number | 3481 |
| Indication | Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery. Consideration should be given to official guidance on the appropriate use of antibacterial agents, including guidance on antibiotic prophylaxis in eye surgery |
| Company | Bausch & Lomb UK Ltd |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 09/08/2017 |